Notice of Extraordinary General Meeting 7 November 2016
(Oslo, Norway, 14 October 2016) An Extraordinary General Meeting of Bionor Pharma ASA will be held on Monday 7 November 2016 at 16:30 hours at KS Agenda Møtesenter, Haakon VIIs gate 9 in Oslo, Norway.
STOCK EXCHANGE ANNOUNCEMENT
Due to the recent issuance of new shares in the private placement and the rights offering the current authorization to the Board to issue new shares is in the view of the board insufficient. The Board finds it necessary that the company has flexibility to issue new shares on short notice in order to be able to obtain additional funding for the Company, strategic measures and/or future operations. The Board accordingly call the EGM to propose to the shareholders to resolve a new authorization to the Board to issue shares in the Company.
The notice of the Extraordinary General Meeting on 7 November 2016 is attached hereto and includes detailed registration and proxy instructions.
All relevant documents and link to online registration of attendance and advance voting can be found on www.bionorpharma.com.
Link to online registration of attendance and advance voting please click here.
Please note that to attend the Extraordinary General Meeting, attendants must be registered shareholders five working days prior to the meeting – 31 October 2016.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Unni Hjelmaas, Acting CEO, +47 915 19 651, firstname.lastname@example.org
Link for announcement in pdf
Notice in pdf